Closing the workforce gap

The Health Foundation, Kings Fund and Nuffield Trust recently published a report Closing the Gap: key areas for action on the health and care workforce. The report looked at two areas – nursing and general practice, both very relevant to MSK health care. At the moment the future looks bleak, with 41,000 nursing vacancies in the NHS and another 5,000 in social care. There are 2,500 fewer GPs than are needed. The report, however, is optimistic that these shortfalls … Read this article

Universal Personalised Care – a summary

Since the NHS Long Term Plan (LTP) was published on 7 January 2019, the Universal Personalised Care: Implementing the Comprehensive Model has been published.

The document defines personalised care: people have choice and control over the way their care is planned and delivered based on ‘what matters’ to them and their individual strengths, needs and preferences.

There are six components to the model:

  1. Shared decision making
  2. Personalised care and support planning
  3. Enabling choice, including legal rights to choice
  4. Social prescribing
Read this article

CEO update: The NHS Long-Term Plan – it’s what happens next that matters

NHS logo

by Sue Brown, CEO ARMA

The NHS Long-Term plan was published earlier this week. I was pleased to see quite a bit about musculoskeletal health throughout the document. There has been lots of immediate reaction, positive and negative. I think now is the time to focus on the positive, so here are my highlights.

The first reference to musculoskeletal health comes early on, (para 1.17) but seems to be mostly about frailty and older people. Great, I thought … Read this article

ARMA Annual lecture: Dame Carol Black

Musculoskeletal conditions, disability and employment

Dame Carol Black is the outstanding expert advisor on health and work and principal of Newnham College Cambridge. Her lecture, delivered in London as part of the ARMA Annual Lecture series, was on progress to date by government, health professionals and employers on musculoskeletal conditions and their impact on employment and a person’s wellbeing.

The lecture and reception was well attended with an interesting Q&A session and lively twitter dialog using #MSKatWork.

You can … Read this article

Belimumab (Benlysta) approved for restricted use in NHS Scotland

On Monday 8th May 2017 the Scottish Medicines Consortium (SMC) published new advice accepting the restricted use of belimumab (Benlysta) by NHS Scotland for lupus patients. This advice was published following a re-submission with evidence supplied by GlaxoSmithKline (the producers of Benlysta) and LUPUS UK on behalf of patients.

 

Belimumab is the first drug approved to treat lupus in more than 50 years and is the first drug developed specifically for lupus since the disease was discovered. It … Read this article

Next Steps on the NHS Five Year Forward View

The Next Steps on the NHS Five Year Forward View document was published on March 31st 2017 as an update to the original Five Year Forward View published in October 2014.

Next Steps sets out the NHS’ main national service improvement priorities over the next two years, “within the constraints of what is necessary to achieve financial balance across the health service”.

This blog post sets out why MSK is so important for the delivery of the next steps … Read this article

Musculoskeletal Services: the missing step

Last Friday, March 31st, NHS England published a significant document about the future of the NHS: Next Steps on the NHS Five Year Forward View. The original NHS five year forward view set out why and how the NHS should change to address three issues: the health gap, the quality gap and the financial sustainability gap. The next steps updates on progress and sets out future plans.

Musculoskeletal conditions account for a major part of the workload

Read this article